Anima Biotech

Anima Biotech is advancing Translation Control Therapeutics, the first platform for discovering small molecule drugs that selectively control mRNA translation as a new strategy for targeting various diseases. By utilizing novel biological technologies to monitor protein translation and proprietary cloud-based software, we can identify drug candidates capable of modulating the production of target proteins.